A Study Investigating the Safety, Absorption and Elimination of GLPG3312, a New Drug in the Treatment of Inflammatory Diseases

GLPG3312 IR tablets, up to 4 single ascending oral doses (A, B, C, D).

Placebo tablets

GLPG3312 MR film-coated tablets, up to 4 single ascending oral doses (H, I, J, K).

GLPG3312 MR film-coated tablets, single oral dose (N) on 2 occasions, i.e. in fed state after a high-fat high-calorie breakfast, and in fasted state.

GLPG3312 MR film-coated tablets, up to 2 multiple ascending oral doses (O, P).

GLPG3312 MR optimized film-coated tablets, up to 3 multiple ascending oral doses (Q, R, S).

Placebo optimized tablets